Osteoporosis International

, Volume 17, Issue 7, pp 1008–1012 | Cite as

Bisphosphonates in pregnancy and lactation-associated osteoporosis

  • S. M. O’SullivanEmail author
  • A. B. Grey
  • R. Singh
  • I. R. Reid
Original Article



Pregnancy and lactation-associated osteoporosis (PLO) is an uncommon condition characterized by the occurrence of fracture(s) during late pregnancy or the puerperium. The aetiology is uncertain, and its management and natural history poorly defined.


We report a series of 11 women with PLO seen at our institution over the past 20 years, with follow-up ranging from 1 to 19 years.


Ten women presented with painful low-trauma vertebral fractures, at a median of 1 month postpartum. In nine cases the fractures were multiple (median: 3, range: 2–5). At least one recognised risk factor for osteoporosis (low body weight, smoking history, family history of osteoporosis/fracture, vitamin D insufficiency) was present in nine patients. Bone density was in the osteoporotic range at the spine (mean T score: −2.8), with less marked reduction at the proximal femur (mean T score: −1.9). Nine patients received bisphosphonate treatment, for a median duration of 24 months. In the five women who received a bisphosphonate within 1 year of presentation, spinal bone density increased by 23% over baseline values after 2 years of treatment (p=0.0014). Of the 5 women who had subsequent pregnancies, one, who had declined bisphosphonate therapy after the initial presentation, sustained a fracture in the postpartum period. Two patients (both of whom were followed for at least 10 years) sustained fractures outside of pregnancy.


PLO is therefore associated with significant morbidity, a high prevalence of recognized risk factors for osteoporosis and a risk of recurrence in subsequent pregnancies. Bisphosphonate therapy administered soon after presentation substantially increases spinal bone density in patients with PLO.


Bisphosphonates Lactation Osteoporosis Pregnancy 



This work was supported by grants from the Australian and New Zealand Bone and Mineral Society (Dr. O’Sullivan) and by the Health Research Council of New Zealand.


  1. 1.
    VanHouten JN, Wysolmerski JJ (2003) Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice. Endocrinology 144:5521–5529PubMedCrossRefGoogle Scholar
  2. 2.
    Reid IR, Wattie DJ, Evans MC, Budayr AA (1992) Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol (Oxf) 37:298–303Google Scholar
  3. 3.
    Sowers MF, Hollis BW, Shapiro B et al (1996) Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276:549–554PubMedCrossRefGoogle Scholar
  4. 4.
    Khovidhunkit W, Epstein S (1996) Osteoporosis in pregnancy. Osteoporos Int 6:345–354PubMedCrossRefGoogle Scholar
  5. 5.
    Carbone LD, Palmieri GM, Graves SC, Smull K (1995) Osteoporosis of pregnancy: long-term follow-up of patients and their offspring. Obstet Gynecol 86:664–666PubMedCrossRefGoogle Scholar
  6. 6.
    Burrows HJ, Graham G (1945) Spinal osteoporosis of unknown origin. Q J Med 14:147–169Google Scholar
  7. 7.
    Albright F, Reifenstein EC (1948) The parathyroid glands and metabolic bone disease. Williams and Wilkins, BaltimoreGoogle Scholar
  8. 8.
    Jones OV (1953) Crush fracture of the dorsal spine in eclampsia. J Obstet Gynaecol Br Commonw 60:259–262Google Scholar
  9. 9.
    Nordin BEC, Roper A (1955) Post-pregnancy osteoporosis. Lancet 268:431–434PubMedCrossRefGoogle Scholar
  10. 10.
    Jackson WP (1958) Osteoporosis of unknown cause in younger people: idiopathic osteoporosis. J Bone Joint Surg Br 40:420–441PubMedGoogle Scholar
  11. 11.
    Hall JW, Kennedy BJ (1961) Idiopathic osteoporosis. Arch Intern Med 108:448–455PubMedGoogle Scholar
  12. 12.
    Dent CE, Friedman M (1965) Pregnancy and idiopathic osteoporosis. Q J Med 34:341–357PubMedGoogle Scholar
  13. 13.
    Gruber HE, Gutteridge DH, Baylink DJ (1984) Osteoporosis associated with pregnancy and lactation: bone biopsy and skeletal features in three patients. Metab Bone Dis Relat Res 5:159–165PubMedCrossRefGoogle Scholar
  14. 14.
    Smith R, Athanasou NA, Ostlere SJ, Vipond SE (1995) Pregnancy-associated osteoporosis. QJM 88:865–878PubMedGoogle Scholar
  15. 15.
    Lam SY, Evans JH, Quinn MA, Baker HW (1987) Postpartum spinal wedge fractures in a 27-year-old epileptic anorectic woman. Aust N Z J Obstet Gynaecol 27:71–74PubMedGoogle Scholar
  16. 16.
    Kinsella P, O’Brien T, Brosnan E, O’Sullivan DJ (1991) A case of pregnancy associated osteoporosis and empty sella syndrome. Ir Med J 84:25–26PubMedGoogle Scholar
  17. 17.
    Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39:487–490Google Scholar
  18. 18.
    Yamamoto N, Takahashi HE, Tanizawa T, Kawashima T, Endo N (1994) Bone mineral density and bone histomorphometric assessments of postpregnancy osteoporosis: a report of five patients. Calcif Tissue Int 54:20–25PubMedCrossRefGoogle Scholar
  19. 19.
    Khan AA, Ahmed MM, Pritzker KPH (1995) Osteoporosis associated with pregnancy: case report and review. Endocr Pract 1:236–238Google Scholar
  20. 20.
    Breuil V, Brocq O, Euller-Ziegler L, Grimaud A (1997) Insufficiency fracture of the sacrum revealing a pregnancy associated osteoporosis. First case report. Ann Rheum Dis 56:278–279PubMedCrossRefGoogle Scholar
  21. 21.
    Vandecandelaere M, Cortet B, Flipo RM, Duquesnoy B, Delcambre B (1997) Osteoporosis in pregnancy: apropos of 2 cases. Rev Med Interne 18:571–574PubMedCrossRefGoogle Scholar
  22. 22.
    Liel Y, Atar D, Ohana N (1998) Pregnancy-associated osteoporosis: preliminary densitometric evidence of extremely rapid recovery of bone mineral density. South Med J 91:33–35PubMedGoogle Scholar
  23. 23.
    Schmid L, Pfirrmann C, Hess T, Schlumpf U (1999) Bilateral fracture of the sacrum associated with pregnancy: a case report. Osteoporos Int 10:91–93PubMedCrossRefGoogle Scholar
  24. 24.
    Di Gregorio S, Danilowicz K, Rubin Z, Mautalen C (2000) Osteoporosis with vertebral fractures associated with pregnancy and lactation. Nutrition 16:1052–1055PubMedCrossRefGoogle Scholar
  25. 25.
    Anai T, Tomiyasu T, Arima K, Miyakawa I (1999) Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J Obstet Gynaecol Res 25:63–67PubMedCrossRefGoogle Scholar
  26. 26.
    Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 11:449–454PubMedCrossRefGoogle Scholar
  27. 27.
    Jensen JE, Mortensen G (2000) Graviditetsinduceret osteoporose. Ugeskr Laeger 162:3865–3866PubMedGoogle Scholar
  28. 28.
    Clemetson IA, Popp A, Lippuner K, Ballmer F, Anderson SE (2004) Postpartum osteoporosis associated with proximal tibial stress fracture. Skeletal Radiol 33:96–98PubMedCrossRefGoogle Scholar
  29. 29.
    Baszko-Blaszyk D, Horst-Sikorska W, Sowinski J (2005) Pregnancy-associated osteoporosis manifesting for the first time during second pregnancy. Ginekol Pol 76:67–69PubMedGoogle Scholar
  30. 30.
    Blanch J, Pacifici R, Chines A (1994) Pregnancy-associated osteoporosis: report of two cases with long-term bone density follow-up. Br J Rheumatol 33:269–272PubMedCrossRefGoogle Scholar
  31. 31.
    Sarikaya S, Ozdolap S, Acikgoz G, Erdem CZ (2004) Pregnancy-associated osteoporosis with vertebral fractures and scoliosis. Joint Bone Spine 71:84–85PubMedCrossRefGoogle Scholar
  32. 32.
    Sowers M (1996) Pregnancy and lactation are risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 15:557–563Google Scholar
  33. 33.
    Moya F, Peris P, Guanabens N et al (1993) Osteoporosis associated with pregnancy. Description of 3 cases. Med Clin (Barc) 100:743–745Google Scholar
  34. 34.
    Parnell W, Wilson N, Faed J et al (1999) NZ food, NZ people: key results of the 1997 National Nutrition Survey. Ministry of Health, WellingtonGoogle Scholar
  35. 35.
    Cranney A, Tugwell P, Adachi J et al (2002) Meta-analyses of therapies for post-menopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:517–523PubMedCrossRefGoogle Scholar
  36. 36.
    Cranney A, Wells G, Willan A et al (2002) Meta-analyses of therapies for post-menopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23:508–516PubMedCrossRefGoogle Scholar
  37. 37.
    Ott SM (2005) Long-term safety of bisphosphonates. J Clin Endocrinol Metab 90:1897–1899PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2006

Authors and Affiliations

  • S. M. O’Sullivan
    • 1
    Email author
  • A. B. Grey
    • 1
  • R. Singh
    • 1
  • I. R. Reid
    • 1
  1. 1.Department of MedicineUniversity of AucklandAucklandNew Zealand

Personalised recommendations